BIORESTORATIVE THERAPIES INC (BRTX) Stock Analyst Ratings
USA - NASDAQ:BRTX - US0906556065 - Common Stock
1.41 USD
+0.03 (+2.17%)
ChartMill assigns a Buy % Consensus number of 83% to BRTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.16. This target is 478.72% above the current price.
BRTX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BRTX.
In the previous month the buy percentage consensus was at a similar level.
BRTX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-14 | Roth MKM | Maintains | Buy -> Buy |
| 2024-06-12 | Roth MKM | Maintains | Buy -> Buy |
| 2023-08-14 | Roth MKM | Reiterate | Buy -> Buy |
| 2022-12-07 | Roth Capital | Initiate | Buy |
| 2022-09-28 | Maxim Group | Initiate | Buy |
| 2021-12-01 | Roth Capital | Initiate | Buy |
BIORESTORATIVE THERAPIES INC / BRTX FAQ
What do analysts expect the price target to be for BIORESTORATIVE THERAPIES INC (BRTX)?
8 analysts have analysed BRTX and the average price target is 8.16 USD. This implies a price increase of 478.72% is expected in the next year compared to the current price of 1.41.
Can you provide the consensus rating for BIORESTORATIVE THERAPIES INC stock?
The consensus rating for BIORESTORATIVE THERAPIES INC (BRTX) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed BIORESTORATIVE THERAPIES INC (BRTX)?
The number of analysts covering BIORESTORATIVE THERAPIES INC (BRTX) is 8.